// App-Quantinova.ai

4057 : Treatment of AL Amyloidosis with Bendamustine

Researchers

Presenter

  • Stefan O Schonland

Principal Investigators

  • Paolo Milani

  • Christoph Kimmich

  • Andrea Foli

  • Tilmann Bochtler

  • Giampaolo Merlini

  • Ute Hegenbart

Medical Centers

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

  • University Clinic Heidelberg, Heidelberg, Germany

  • Amyloidosis Center, University of Heidelberg, Heidelberg, Germany

Locations

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Cardiac amyloidosis

  • Multiple Myeloma

  • AL Amyloidosis

  • Renal insufficiency

  • Amyloid disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bendamustine

  • Lenalidomide

  • Bortezomib

  • Prednisone

  • Melphalan

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved